Metraipolis › archive › dc_aa258db9acb0

Targeting c-Myc enhances immunotherapy efficacy in combination with Ras inhibitor in triple-negative breast cancer — Europe PMC PMID:41020311

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41020311
DOI
10.1002/ctm2.70484
License (as archived)
solo-consultazione
Archived
2026-11-09T16:19:58.611Z
SHA-256 of the archived text
6d2484f91b3014d0ccffb4ca634414c6515b268fd3ef11effe3369fcedbdfc70
Stable URL of this page
https://metraipolis.com/documento/dc_aa258db9acb0

How to cite

Targeting c-Myc enhances immunotherapy efficacy in combination with Ras inhibitor in triple-negative breast cancer — Europe PMC PMID:41020311 — Europe PMC (en), https://europepmc.org/article/MED/41020311 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_aa258db9acb0 (Metraipolis archive dc_aa258db9acb0, sha256 6d2484f91b3014d0ccffb4ca634414c6515b268fd3ef11effe3369fcedbdfc70)
BibTeX
@misc{dcaa258db9acb0,
  title = {Targeting c-Myc enhances immunotherapy efficacy in combination with Ras inhibitor in triple-negative breast cancer — Europe PMC PMID:41020311},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41020311},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_aa258db9acb0; sha256 6d2484f91b3014d0ccffb4ca634414c6515b268fd3ef11effe3369fcedbdfc70},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41020311. Agents can read the archived copy with the MCP tool read_document.